Xenon Pharmaceuticals (XENE) Receivables - Other (2019 - 2026)
Xenon Pharmaceuticals' (XENE) quarterly Receivables - Other came in at $1.2 million in Q1 2026, down 83.77% year-on-year from $7.2 million in Q1 2025, and up 108.41% on a QoQ basis from $559000.0 in Q4 2025.
Xenon Pharmaceuticals (XENE) Receivables - Other (2019 - 2026) Analysis & Trends
Xenon Pharmaceuticals (XENE) has 4 years of Receivables - Other data on file, last reported at $1.2 million in Q1 2026.
- On a quarterly basis, Receivables - Other fell 83.77% year-over-year to $1.2 million in Q1 2026; TTM through Mar 2026 was $1.2 million, a N/A change from a year earlier, with the FY2025 full-year figure at $1.4 million, down 6.67% from the prior year.
- Receivables - Other for Q1 2026 stood at $1.2 million, up from $559000.0 in the prior quarter.
- Over the last five years, Receivables - Other for XENE reached as high as $7.2 million in Q1 2025 and fell as low as $83000.0 in Q3 2024.
- Historically, Receivables - Other has averaged $1.6 million across 3 years, with a median of $812000.0 in 2025.
- Across the five-year window, Receivables - Other surged 878.31% in 2025 and slumped 83.77% in 2026, its largest moves.
- Year by year, Receivables - Other stood at $547000.0 in 2024, then rose by 2.19% to $559000.0 in 2025, then jumped by 108.41% to $1.2 million in 2026.
- Per Business Quant data, the three most recent Receivables - Other figures were $1.2 million in Q1 2026, $559000.0 in Q4 2025, and $812000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Xenon Pharmaceuticals | 5.71 Bn | 5.71 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.17 Mn |
| Mar 31, 2026 | 1.17 Mn |
| Dec 31, 2025 | 559,000.00 |
| Dec 31, 2025 | 559,000.00 |
| Sep 30, 2025 | 812,000.00 |
| Sep 30, 2025 | 812,000.00 |
| Jun 30, 2025 | 1.10 Mn |
| Jun 30, 2025 | 1.10 Mn |
| Mar 31, 2025 | 7.18 Mn |
| Mar 31, 2025 | 7.18 Mn |
| Dec 31, 2024 | 547,000.00 |
| Dec 31, 2024 | 547,000.00 |
| Sep 30, 2024 | 83,000.00 |
| Sep 30, 2024 | 83,000.00 |
| Dec 31, 2019 | 448,000.00 |
| Dec 31, 2019 | 448,000.00 |